10-Q Filing
Filing Information
| Form Type | 10-Q |
| Accession Number | 0001628280-22-012960 |
| Period End Date | 20220331 |
| Filing Date | 20220506 |
| Fiscal Year | 2022 |
| Fiscal Period | Q1 |
| XBRL Instance | jynt-20220331_htm.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
105 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$18.25M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$17.83M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$19.53M | USD | Point-in-time |
| Restricted cash |
RestrictedCashAndCashEquivalentsAtCarryingValue
|
$386.22K | USD | Point-in-time |
| Restricted cash |
RestrictedCashAndCashEquivalentsAtCarryingValue
|
$594.72K | USD | Point-in-time |
| Accounts receivable, net |
AccountsReceivableNetCurrent
|
$3.70M | USD | Point-in-time |
| Accounts receivable, net |
AccountsReceivableNetCurrent
|
$3.61M | USD | Point-in-time |
| Deferred franchise and regional development costs, current portion |
ContractWithCustomerAssetNetCurrent
|
$994.59K | USD | Point-in-time |
| Payroll liabilities ($0.7 million and $0.4 million attributable to VIE) |
EmployeeRelatedLiabilitiesCurrent
|
$2.38M | USD | Point-in-time |
| Deferred franchise and regional development costs, current portion |
ContractWithCustomerAssetNetCurrent
|
$985.56K | USD | Point-in-time |
| Payroll liabilities ($0.7 million and $0.4 million attributable to VIE) |
EmployeeRelatedLiabilitiesCurrent
|
$3.91M | USD | Point-in-time |
| Prepaid expenses and other current assets |
PrepaidExpenseAndOtherAssetsCurrent
|
$2.43M | USD | Point-in-time |
| Deferred revenue from company clinics attributable to VIE |
ContractWithCustomerLiabilityCurrent
|
$3.13M | USD | Point-in-time |
| Prepaid expenses and other current assets |
PrepaidExpenseAndOtherAssetsCurrent
|
$2.28M | USD | Point-in-time |
| Deferred revenue from company clinics attributable to VIE |
ContractWithCustomerLiabilityCurrent
|
$3.19M | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$26.89M | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$25.87M | USD | Point-in-time |
| Series A preferred stock, par value (in dollars per share) |
PreferredStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Series A preferred stock, par value (in dollars per share) |
PreferredStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
|
$14.88M | USD | Point-in-time |
| Series A preferred stock, shares authorized (in shares) |
PreferredStockSharesAuthorized
|
50,000.00 | shares | Point-in-time |
| Series A preferred stock, shares authorized (in shares) |
PreferredStockSharesAuthorized
|
50,000.00 | shares | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
|
$14.39M | USD | Point-in-time |
| Operating lease right-of-use asset |
OperatingLeaseRightOfUseAsset
|
$18.93M | USD | Point-in-time |
| Series A preferred stock, shares issued (in shares) |
PreferredStockSharesIssued
|
0.00 | shares | Point-in-time |
| Operating lease right-of-use asset |
OperatingLeaseRightOfUseAsset
|
$18.43M | USD | Point-in-time |
| Series A preferred stock, shares issued (in shares) |
PreferredStockSharesIssued
|
0.00 | shares | Point-in-time |
| Series A preferred stock, shares outstanding (in shares) |
PreferredStockSharesOutstanding
|
0.00 | shares | Point-in-time |
| Series A preferred stock, shares outstanding (in shares) |
PreferredStockSharesOutstanding
|
0.00 | shares | Point-in-time |
| Deferred franchise and regional development costs, net of current portion |
ContractWithCustomerAssetNetNoncurrent
|
$5.60M | USD | Point-in-time |
| Deferred franchise and regional development costs, net of current portion |
ContractWithCustomerAssetNetNoncurrent
|
$5.51M | USD | Point-in-time |
| Intangible assets, net |
IntangibleAssetsNetExcludingGoodwill
|
$5.40M | USD | Point-in-time |
| Intangible assets, net |
IntangibleAssetsNetExcludingGoodwill
|
$4.83M | USD | Point-in-time |
| Common stock, par value (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Common stock, par value (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Common stock, shares authorized (in shares) |
CommonStockSharesAuthorized
|
20.00M | shares | Point-in-time |
| Goodwill |
Goodwill
|
$5.09M | USD | Point-in-time |
| Goodwill |
Goodwill
|
$5.09M | USD | Point-in-time |
| Common stock, shares authorized (in shares) |
CommonStockSharesAuthorized
|
20.00M | shares | Point-in-time |
| Common stock, shares issued (in shares) |
CommonStockSharesIssued
|
14.45M | shares | Point-in-time |
| Deferred tax assets |
DeferredIncomeTaxAssetsNet
|
$9.21M | USD | Point-in-time |
| Common stock, shares issued (in shares) |
CommonStockSharesIssued
|
14.49M | shares | Point-in-time |
| Deferred tax assets |
DeferredIncomeTaxAssetsNet
|
$9.19M | USD | Point-in-time |
| Deposits and other assets |
DepositsAssetsNoncurrent
|
$662.08K | USD | Point-in-time |
| Common stock, shares outstanding (in shares) |
CommonStockSharesOutstanding
|
14.42M | shares | Point-in-time |
| Deposits and other assets |
DepositsAssetsNoncurrent
|
$567.20K | USD | Point-in-time |
| Common stock, shares outstanding (in shares) |
CommonStockSharesOutstanding
|
14.46M | shares | Point-in-time |
| Total assets |
Assets
|
$85.06M | USD | Point-in-time |
| Total assets |
Assets
|
$85.45M | USD | Point-in-time |
| Treasury stock, shares (in shares) |
TreasuryStockShares
|
31,643.00 | shares | Point-in-time |
| Treasury stock, shares (in shares) |
TreasuryStockShares
|
31,717.00 | shares | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$1.87M | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$1.71M | USD | Point-in-time |
| Accrued expenses |
AccruedLiabilitiesCurrent
|
$1.81M | USD | Point-in-time |
| Accrued expenses |
AccruedLiabilitiesCurrent
|
$1.64M | USD | Point-in-time |
| Co-op funds liability |
CoOpFundsLiabilityCurrent
|
$386.22K | USD | Point-in-time |
| Co-op funds liability |
CoOpFundsLiabilityCurrent
|
$594.72K | USD | Point-in-time |
| Payroll liabilities ($0.7 million and $0.4 million attributable to VIE) |
EmployeeRelatedLiabilitiesCurrent
|
$2.38M | USD | Point-in-time |
| Payroll liabilities ($0.7 million and $0.4 million attributable to VIE) |
EmployeeRelatedLiabilitiesCurrent
|
$3.91M | USD | Point-in-time |
| Operating lease liability, current portion |
OperatingLeaseLiabilityCurrent
|
$4.87M | USD | Point-in-time |
| Operating lease liability, current portion |
OperatingLeaseLiabilityCurrent
|
$4.61M | USD | Point-in-time |
| Finance lease liability, current portion |
FinanceLeaseLiabilityCurrent
|
$49.85K | USD | Point-in-time |
| Finance lease liability, current portion |
FinanceLeaseLiabilityCurrent
|
$34.48K | USD | Point-in-time |
| Deferred franchise and regional developer fee revenue, current portion |
ContractWithCustomerLiabilityCurrent
|
$3.13M | USD | Point-in-time |
| Deferred franchise and regional developer fee revenue, current portion |
ContractWithCustomerLiabilityCurrent
|
$3.19M | USD | Point-in-time |
| Deferred revenue from company clinics ($3.6 million and $3.5 million attributable to VIE) |
DeferredRevenueFromCompanyClinicsCurrent
|
$5.55M | USD | Point-in-time |
| Deferred revenue from company clinics ($3.6 million and $3.5 million attributable to VIE) |
DeferredRevenueFromCompanyClinicsCurrent
|
$5.24M | USD | Point-in-time |
| Other current liabilities |
OtherLiabilitiesCurrent
|
$539.50K | USD | Point-in-time |
| Other current liabilities |
OtherLiabilitiesCurrent
|
$541.25K | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$20.62M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$21.44M | USD | Point-in-time |
| Operating lease liability, net of current portion |
OperatingLeaseLiabilityNoncurrent
|
$17.18M | USD | Point-in-time |
| Operating lease liability, net of current portion |
OperatingLeaseLiabilityNoncurrent
|
$16.87M | USD | Point-in-time |
| Finance lease liability, net of current portion |
FinanceLeaseLiabilityNoncurrent
|
$87.94K | USD | Point-in-time |
| Finance lease liability, net of current portion |
FinanceLeaseLiabilityNoncurrent
|
$81.93K | USD | Point-in-time |
| Debt under the Credit Agreement |
LineOfCredit
|
$2.00M | USD | Point-in-time |
| Debt under the Credit Agreement |
LineOfCredit
|
$2.00M | USD | Point-in-time |
| Deferred franchise and regional developer fee revenue, net of current portion |
ContractWithCustomerLiabilityNoncurrent
|
$15.41M | USD | Point-in-time |
| Deferred franchise and regional developer fee revenue, net of current portion |
ContractWithCustomerLiabilityNoncurrent
|
$15.46M | USD | Point-in-time |
| Other liabilities |
OtherLiabilitiesNoncurrent
|
$27.23K | USD | Point-in-time |
| Other liabilities |
OtherLiabilitiesNoncurrent
|
$27.23K | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$55.88M | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$55.33M | USD | Point-in-time |
| Commitments and contingencies |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Commitments and contingencies |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Series A preferred stock, $0.001 par value; 50,000 shares authorized, 0 issued and outstanding, as of March 31, 2022 and December 31, 2021 |
PreferredStockValue
|
- | USD | Point-in-time |
| Series A preferred stock, $0.001 par value; 50,000 shares authorized, 0 issued and outstanding, as of March 31, 2022 and December 31, 2021 |
PreferredStockValue
|
- | USD | Point-in-time |
| Common stock, $0.001 par value; 20,000,000 shares authorized, 14,493,049 shares issued and 14,461,332 shares outstanding as of March 31, 2022 and 14,451,355 shares issued and 14,419,712 outstanding as of December 31, 2021 |
CommonStockValue
|
$14.45K | USD | Point-in-time |
| Common stock, $0.001 par value; 20,000,000 shares authorized, 14,493,049 shares issued and 14,461,332 shares outstanding as of March 31, 2022 and 14,451,355 shares issued and 14,419,712 outstanding as of December 31, 2021 |
CommonStockValue
|
$14.49K | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapital
|
$43.90M | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapital
|
$44.27M | USD | Point-in-time |
| Treasury stock 31,717 shares as of March 31, 2022 and 31,643 shares as of December 31, 2021, at cost |
TreasuryStockValue
|
$850.84K | USD | Point-in-time |
| Treasury stock 31,717 shares as of March 31, 2022 and 31,643 shares as of December 31, 2021, at cost |
TreasuryStockValue
|
$853.44K | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-13.52M | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-13.72M | USD | Point-in-time |
| Total The Joint Corp. stockholders' equity |
StockholdersEquity
|
$29.54M | USD | Point-in-time |
| Total The Joint Corp. stockholders' equity |
StockholdersEquity
|
$29.71M | USD | Point-in-time |
| Non-controlling Interest |
MinorityInterest
|
$25.00K | USD | Point-in-time |
| Non-controlling Interest |
MinorityInterest
|
$25.00K | USD | Point-in-time |
| Total equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$21.13M | USD | Point-in-time |
| Total equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$29.57M | USD | Point-in-time |
| Total equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$29.73M | USD | Point-in-time |
| Total equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$23.69M | USD | Point-in-time |
| Total liabilities and stockholders' equity |
LiabilitiesAndStockholdersEquity
|
$85.45M | USD | Point-in-time |
| Total liabilities and stockholders' equity |
LiabilitiesAndStockholdersEquity
|
$85.06M | USD | Point-in-time |
Income Statement
32 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Total revenues |
RevenueFromContractWithCustomerIncludingAssessedTax
|
$17.55M | USD | 1 Quarter |
| Total revenues |
RevenueFromContractWithCustomerIncludingAssessedTax
|
$22.44M | USD | 1 Quarter |
| Total cost of revenues |
CostOfRevenue
|
$1.77M | USD | 1 Quarter |
| Total cost of revenues |
CostOfRevenue
|
$2.31M | USD | 1 Quarter |
| Selling and marketing expenses |
SellingAndMarketingExpense
|
$3.29M | USD | 1 Quarter |
| Selling and marketing expenses |
SellingAndMarketingExpense
|
$2.49M | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationAndAmortization
|
$1.17M | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationAndAmortization
|
$1.63M | USD | 1 Quarter |
| General and administrative expenses |
GeneralAndAdministrativeExpense
|
$15.38M | USD | 1 Quarter |
| General and administrative expenses |
GeneralAndAdministrativeExpense
|
$10.09M | USD | 1 Quarter |
| Total selling, general and administrative expenses |
SellingGeneralAndAdministrativeExpense
|
$20.30M | USD | 1 Quarter |
| Total selling, general and administrative expenses |
SellingGeneralAndAdministrativeExpense
|
$13.75M | USD | 1 Quarter |
| Net loss on disposition or impairment |
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
|
$-6.91K | USD | 1 Quarter |
| Net loss on disposition or impairment |
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
|
$-64.77K | USD | 1 Quarter |
| (Loss) income from operations |
OperatingIncomeLoss
|
$-176.43K | USD | 1 Quarter |
| (Loss) income from operations |
OperatingIncomeLoss
|
$1.97M | USD | 1 Quarter |
| Other expense, net |
OtherNonoperatingIncomeExpense
|
$-21.54K | USD | 1 Quarter |
| Other expense, net |
OtherNonoperatingIncomeExpense
|
$-16.15K | USD | 1 Quarter |
| (Loss) income before income tax benefit |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$1.95M | USD | 1 Quarter |
| (Loss) income before income tax benefit |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$-192.57K | USD | 1 Quarter |
| Income tax expense (benefit) |
IncomeTaxExpenseBenefit
|
$-364.15K | USD | 1 Quarter |
| Income tax expense (benefit) |
IncomeTaxExpenseBenefit
|
$13.22K | USD | 1 Quarter |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total |
ProfitLoss
|
$2.31M | USD | 1 Quarter |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total |
ProfitLoss
|
$-205.80K | USD | 1 Quarter |
| Basic earnings per share (in dollars per share) |
EarningsPerShareBasic
|
$-0.01 | USD | 1 Quarter |
| Basic earnings per share (in dollars per share) |
EarningsPerShareBasic
|
$0.16 | USD | 1 Quarter |
| Diluted earnings per share (in dollars per share) |
EarningsPerShareDiluted
|
$0.16 | USD | 1 Quarter |
| Diluted earnings per share (in dollars per share) |
EarningsPerShareDiluted
|
$-0.01 | USD | 1 Quarter |
| Basic weighted average shares (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
14.43M | shares | 1 Quarter |
| Basic weighted average shares (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
14.18M | shares | 1 Quarter |
| Diluted weighted average shares (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
14.85M | shares | 1 Quarter |
| Diluted weighted average shares (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
14.43M | shares | 1 Quarter |
Cash Flow Statement
67 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net (loss) income |
NetIncomeLoss
|
$-205.80K | USD | 1 Quarter |
| Net (loss) income |
NetIncomeLoss
|
$2.31M | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$1.63M | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$1.17M | USD | 1 Quarter |
| Net loss on disposition or impairment (non-cash portion) |
GainLossOnDispositionOfAssets1
|
$-99.02K | USD | 1 Quarter |
| Net loss on disposition or impairment (non-cash portion) |
GainLossOnDispositionOfAssets1
|
$-6.91K | USD | 1 Quarter |
| Net franchise fees recognized upon termination of franchise agreements |
GainLossOnTerminationOfFranchisingAgreements
|
$69.70K | USD | 1 Quarter |
| Net franchise fees recognized upon termination of franchise agreements |
GainLossOnTerminationOfFranchisingAgreements
|
- | USD | 1 Quarter |
| Deferred income taxes |
DeferredIncomeTaxExpenseBenefit
|
$-16.78K | USD | 1 Quarter |
| Deferred income taxes |
DeferredIncomeTaxExpenseBenefit
|
$-418.81K | USD | 1 Quarter |
| Stock based compensation expense |
ShareBasedCompensation
|
$323.56K | USD | 1 Quarter |
| Stock based compensation expense |
ShareBasedCompensation
|
$246.49K | USD | 1 Quarter |
| Accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$-88.01K | USD | 1 Quarter |
| Accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$442.01K | USD | 1 Quarter |
| Prepaid expenses and other current assets |
IncreaseDecreaseInIncomeTaxesReceivable
|
$144.64K | USD | 1 Quarter |
| Prepaid expenses and other current assets |
IncreaseDecreaseInIncomeTaxesReceivable
|
$384.38K | USD | 1 Quarter |
| Deferred franchise costs |
IncreaseDecreaseInContractWithCustomerAsset
|
$204.11K | USD | 1 Quarter |
| Deferred franchise costs |
IncreaseDecreaseInContractWithCustomerAsset
|
$86.69K | USD | 1 Quarter |
| Deposits and other assets |
IncreaseDecreaseInDepositOtherAssets
|
$94.88K | USD | 1 Quarter |
| Deposits and other assets |
IncreaseDecreaseInDepositOtherAssets
|
$3.31K | USD | 1 Quarter |
| Accounts payable |
IncreaseDecreaseInAccountsPayable
|
$-443.46K | USD | 1 Quarter |
| Accounts payable |
IncreaseDecreaseInAccountsPayable
|
$59.46K | USD | 1 Quarter |
| Accrued expenses |
IncreaseDecreaseInAccruedLiabilities
|
$-164.75K | USD | 1 Quarter |
| Accrued expenses |
IncreaseDecreaseInAccruedLiabilities
|
$60.49K | USD | 1 Quarter |
| Payroll liabilities |
IncreaseDecreaseInEmployeeRelatedLiabilities
|
$-217.02K | USD | 1 Quarter |
| Payroll liabilities |
IncreaseDecreaseInEmployeeRelatedLiabilities
|
$-1.52M | USD | 1 Quarter |
| Deferred revenue |
IncreaseDecreaseInContractWithCustomerLiability
|
$296.49K | USD | 1 Quarter |
| Deferred revenue |
IncreaseDecreaseInContractWithCustomerLiability
|
$329.38K | USD | 1 Quarter |
| Other liabilities |
IncreaseDecreaseInOtherOperatingLiabilities
|
$234.71K | USD | 1 Quarter |
| Other liabilities |
IncreaseDecreaseInOtherOperatingLiabilities
|
$280.16K | USD | 1 Quarter |
| Net cash provided by operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$447.88K | USD | 1 Quarter |
| Net cash provided by operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$2.27M | USD | 1 Quarter |
| Purchase of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$951.64K | USD | 1 Quarter |
| Purchase of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$1.29M | USD | 1 Quarter |
| Reacquisition and termination of regional developer rights |
ReacquisitionAndTerminationOfRegionalDeveloperRights
|
$1.39M | USD | 1 Quarter |
| Reacquisition and termination of regional developer rights |
ReacquisitionAndTerminationOfRegionalDeveloperRights
|
$250.00K | USD | 1 Quarter |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-2.34M | USD | 1 Quarter |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-1.54M | USD | 1 Quarter |
| Payments of finance lease obligation |
FinanceLeasePrincipalPayments
|
$21.39K | USD | 1 Quarter |
| Payments of finance lease obligation |
FinanceLeasePrincipalPayments
|
$18.24K | USD | 1 Quarter |
| Purchases of treasury stock under employee stock plans |
PaymentsForRepurchaseOfCommonStock
|
$618.15K | USD | 1 Quarter |
| Purchases of treasury stock under employee stock plans |
PaymentsForRepurchaseOfCommonStock
|
$2.60K | USD | 1 Quarter |
| Proceeds from exercise of stock options |
ProceedsFromStockOptionsExercised
|
$620.78K | USD | 1 Quarter |
| Proceeds from exercise of stock options |
ProceedsFromStockOptionsExercised
|
$49.62K | USD | 1 Quarter |
| Repayment of debt under the Paycheck Protection Program |
RepaymentsOfNotesPayable
|
$2.73M | USD | 1 Quarter |
| Repayment of debt under the Paycheck Protection Program |
RepaymentsOfNotesPayable
|
- | USD | 1 Quarter |
| Net cash provided by (used in) financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$-2.74M | USD | 1 Quarter |
| Net cash provided by (used in) financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$25.64K | USD | 1 Quarter |
| Decrease in cash, cash equivalents and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$-1.07M | USD | 1 Quarter |
| Decrease in cash, cash equivalents and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$-2.81M | USD | 1 Quarter |
| Cash, cash equivalents and restricted cash, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$19.91M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$18.01M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$20.82M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$18.85M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$19.91M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$18.01M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$20.82M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$18.85M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$18.25M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$17.83M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$19.53M | USD | Point-in-time |
| Restricted cash |
RestrictedCash
|
$594.72K | USD | Point-in-time |
| Restricted cash |
RestrictedCash
|
$172.62K | USD | Point-in-time |
| Cash and cash equivalents and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$19.91M | USD | Point-in-time |
| Cash and cash equivalents and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$18.01M | USD | Point-in-time |
| Cash and cash equivalents and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$20.82M | USD | Point-in-time |
| Cash and cash equivalents and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$18.85M | USD | Point-in-time |
Stockholders Equity
18 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Balance, beginning |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$21.13M | USD | Point-in-time |
| Balance, beginning |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$29.57M | USD | Point-in-time |
| Balance, beginning |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$29.73M | USD | Point-in-time |
| Balance, beginning |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$23.69M | USD | Point-in-time |
| Stock-based compensation expense |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$246.49K | USD | 1 Quarter |
| Stock-based compensation expense |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$323.56K | USD | 1 Quarter |
| Issuance of restricted stock |
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
- | USD | 1 Quarter |
| Issuance of restricted stock |
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
- | USD | 1 Quarter |
| Exercise of stock options |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$620.78K | USD | 1 Quarter |
| Exercise of stock options |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$49.62K | USD | 1 Quarter |
| Purchases of treasury stock under employee stock plans |
TreasuryStockValueAcquiredCostMethod
|
$618.15K | USD | 1 Quarter |
| Purchases of treasury stock under employee stock plans |
TreasuryStockValueAcquiredCostMethod
|
$2.60K | USD | 1 Quarter |
| Net loss |
ProfitLoss
|
$2.31M | USD | 1 Quarter |
| Net loss |
ProfitLoss
|
$-205.80K | USD | 1 Quarter |
| Balance, ending |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$21.13M | USD | Point-in-time |
| Balance, ending |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$29.57M | USD | Point-in-time |
| Balance, ending |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$29.73M | USD | Point-in-time |
| Balance, ending |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$23.69M | USD | Point-in-time |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.